Benzinga | Nov 5, 2020 04:02PM EST

Iovance Biotherapeutics Q3 EPS $(0.40) Beats $(0.46) Estimate

Iovance Biotherapeutics (NASDAQ:IOVA) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.46) by 13.04 percent. This is unchanged from the same period last year.